Control release of mitochondria-targeted antioxidant by injectable self-assembling peptide hydrogel ameliorated persistent mitochondrial dysfunction and inflammation after acute kidney injury

References

• Andres-Hernando A, Altmann C, Bhargava R, et al. (2014). Prolonged acute kidney injury exacerbates lung inflammation at 7 days post-acute kidney injury. Physiol Rep 2:e12084.
   PubMedGoogle Scholar
• Arslan F, de Kleijn DP, Pasterkamp G. (2011). Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 8:292–300.
   PubMed Web of Science ®Google Scholar
• Bhargava P, Schnellmann RG. (2017). Mitochondrial energetics in the kidney. Nat Rev Nephrol 13:629–46.
   PubMed Web of Science ®Google Scholar
• Charlton JR, Portilla D, Okusa MD. (2014). A basic science view of acute kidney injury biomarkers. Nephrol Dial Transplant 29:1301–11.
   PubMed Web of Science ®Google Scholar
• Che R, Yuan Y, Huang S, et al. (2014). Mitochondrial dysfunction in the pathophysiology of renal diseases. Am J Physiol Renal Physiol 306:F367–78.
   PubMed Web of Science ®Google Scholar
• Chen GY, Nunez G. (2010). Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826–37.
   PubMed Web of Science ®Google Scholar
• Chevalier RL. (2016). The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol 311:F145–61.
   PubMed Web of Science ®Google Scholar
• Davis ME, Hsieh PC, Takahashi T. (2006). Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA 103:8155–60.
   PubMed Web of Science ®Google Scholar
• Drose S, Brandt U. (2012). Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol 748:145–69.
   PubMed Web of Science ®Google Scholar
• Duann P, Lin PH. (2017). Mitochondria damage and kidney disease. Adv Exp Med Biol 982:529–51.
   PubMed Web of Science ®Google Scholar
• Funk JA, Schnellmann RG. (2012). Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Renal Physiol 302:F853–64.
   PubMed Web of Science ®Google Scholar
• Gelain F, Unsworth LD, Zhang S. (2010). Slow and sustained release of active cytokines from self-assembling peptide scaffolds. J Control Release 145:231–9.
   PubMed Web of Science ®Google Scholar
• Hall AM, Schuh CD. (2016). Mitochondria as therapeutic targets in acute kidney injury. Curr Opin Nephrol Hypertens 25:355–62.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMonagle E, Freedman S, et al. (2004). Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15:2449–56.
   PubMed Web of Science ®Google Scholar
• Iyer SS, Pulskens WP, Sadler JJ, et al. (2009). Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 106:20388–93.
   PubMed Web of Science ®Google Scholar
• Lameire NH, Bagga A, Cruz D, et al. (2013). Acute kidney injury: an increasing global concern. Lancet 382:170–9.
   PubMed Web of Science ®Google Scholar
• Liang HL, Sedlic F, Bosnjak Z, et al. (2010). SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery. Free Radic Biol Med 49:1550–60.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhao X. (2011). Design of self-assembling peptides and their biomedical applications. Nanomedicine (Lond) 6:1621–43.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang L, Yang Z, et al. (2011). Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro. Int J Nanomedicine 6:2143–53.
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang L, Cheng J, et al. (2016). Sustained release of hepatocyte growth factor by cationic self-assembling peptide/heparin hybrid hydrogel improves beta-cell survival and function through modulating inflammatory response. Int J Nanomedicine 11:4875–90.
   PubMed Web of Science ®Google Scholar
• Loor G, Kondapalli J, Iwase H, et al. (2011). Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion. Biochim Biophys Acta 1813:1382–94.
   PubMed Web of Science ®Google Scholar
• Lu HD, Charati MB, Kim IL, et al. (2012). Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanism. Biomaterials 33:2145–53.
   PubMed Web of Science ®Google Scholar
• Miura S, Saitoh SI, Kokubun T, et al. (2017). Mitochondrial-targeted antioxidant maintains blood flow, mitochondrial function, and redox balance in old mice following prolonged limb ischemia. Int J Mol Sci 18:E1897.
   PubMed Web of Science ®Google Scholar
• Nagai Y, Unsworth LD, Koutsopoulos S, et al. (2006). Slow release of molecules in self-assembling peptide nanofiber scaffold. J Control Release 115:18–25.
   PubMed Web of Science ®Google Scholar
• Patil NK, Parajuli N, MacMillan-Crow LA, et al. (2014). Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury. Am J Physiol Renal Physiol 306:F734–43.
   PubMed Web of Science ®Google Scholar
• Rodell CB, Rai R, Faubel S, et al. (2015). Local immunotherapy via delivery of interleukin-10 and transforming growth factor beta antagonist for treatment of chronic kidney disease. J Control Release 206:131–9.
   PubMed Web of Science ®Google Scholar
• Soranno DE, Rodell CB, Altmann C, et al. (2016). Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice. Am J Physiol Renal Physiol 311:F362–72.
   PubMed Web of Science ®Google Scholar
• Stallons LJ, Funk JA, Schnellmann RG. (2013). Mitochondrial homeostasis in acute organ failure. Curr Pathobiol Rep 1:169–177.
   PubMedGoogle Scholar
• Szeto HH. (2017). Pharmacologic approaches to improve mitochondrial function in AKI and CKD. J Am Soc Nephrol 28:2856–65.
   PubMed Web of Science ®Google Scholar
• Szeto HH, Liu S, Soong Y, et al. (2017). Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD. J Am Soc Nephrol 28:1437–49.
   PubMed Web of Science ®Google Scholar
• Tabara LC, Poveda J, Martin-Cleary C, et al. (2014). Mitochondria-targeted therapies for acute kidney injury. Expert Rev Mol Med 16:e13.
   PubMed Web of Science ®Google Scholar
• Thadhani R, Pascual M, Bonventre JV. (1996). Acute renal failure. N Engl J Med 334:1448–60.
   PubMed Web of Science ®Google Scholar
• Trnka J, Blaikie FH, Smith RA, et al. (2008). A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria. Free Radic Biol Med 44:1406–19.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang S. (2006). Molecular designer self-assembling peptides. Chem Soc Rev 35:1105–10.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang S. (2007). Designer self-assembling peptide materials. Macromol Biosci 7:13–22.
   PubMed Web of Science ®Google Scholar
• Zhelev Z, Bakalova R, Aoki I, et al. (2013). Imaging of superoxide generation in the dopaminergic area of the brain in Parkinson’s disease, using mito-TEMPO. ACS Chem Neurosci 4:1439–45.
   PubMed Web of Science ®Google Scholar
• Zuk A, Bonventre JV. (2016). Acute kidney injury. Annu Rev Med 67:293–307.
   PubMed Web of Science ®Google Scholar